Key facts
- Caribou Biosciences' price target was raised.
- Investor confidence in Caribou Biosciences' pipeline is growing.
Analyst sentiment towards Caribou Biosciences has improved, reflected in a higher price target. This upgrade is driven by increased investor confidence in the company's drug development pipeline, signaling potential positive future market performance.